Psychedelic drug 'cures' get US boost
The world's largest research centre has been launched to examine whether psychedelic drugs can treat depression, and opioid addiction after tech entrepreneurs helped fuel new interest in the field.
Johns Hopkins University's School of Medicine announced the launch of the new Centre for Psychedelic and Consciousness Research, made possible by a $17m (€15.3m) injection from private donors including the founder of WordPress and a popular podcast host.
It comes amid a surge in interest in psychedelic compounds to treat a range of mental health disorders. The field has been largely neglected since Harvard psychologist Timothy Leary began to investigate how cognitive processes and emotions are affected by mind-altering substances in the 1960s.
Psychedelics have long been illegal in the US, but studies suggesting they may be effective in medical treatments have helped shift perceptions.
The tests will involve between 200-250 volunteers. (© Daily Telegraph, London)